In recently relapsed polymyalgia rheumatica during GC tapering, secukinumab increased sustained remission rates at 1 y. (PubMed, Ann Intern Med) - Oct 6, 2026 - "GIM/FP/GP: [Formula: see text] Rheumatology: [Formula: see text]."
Journal • Immunology • Musculoskeletal Pain • Pain • Polymyalgia Rheumatica • Rheumatology
|